• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

2.850 -0.040 (-1.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 87,993
Open 2.930
Bid (Size) 2.820 (4,200)
Ask (Size) 3.060 (1,000)
Prev. Close 2.890
Today's Range 2.800 - 2.976
52wk Range 2.331 - 5.457
Shares Outstanding 33,376,690
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Anixa Biosciences, Inc. (NASDAQ: ANIX) CAR-T Co-Inventor To Keynote SCTR 2026 Retreat
February 25, 2026
Via Investor Brand Network
Water Tower Research Publishes Initiation of Coverage Report on Anixa Biosciences, Inc., “Anixa’s T-Cell Innovations Show Breakthrough Potential in Solid Tumors”
January 21, 2026
January 21, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Anixa Biosciences, Inc. (NASDAQ: ANIX) titled, “Anixa’s T-Cell... 
Via TheNewswire.com

Performance

YTD
-9.8%
-9.8%
1 Month
-2.4%
-2.4%
3 Month
-40.5%
-40.5%
6 Month
-4.0%
-4.0%
1 Year
-2.4%
-2.4%

More News

Read More
News headline image
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
September 09, 2025
Via MarketBeat
News headline image
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent ↗
April 09, 2025
Via Benzinga
Topics Intellectual Property
News headline image
Recap: Anixa Biosciences Q1 Earnings ↗
March 12, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
April 08, 2025
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines ↗
March 25, 2025
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine ↗
March 24, 2025
Via Benzinga
Topics Intellectual Property
News headline image
This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗
March 21, 2025
Via Benzinga
News headline image
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
December 06, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 30, 2024
Via Benzinga
News headline image
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying ↗
July 29, 2024
Via Benzinga
News headline image
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy ↗
July 23, 2024
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program ↗
July 15, 2024
Via Benzinga
News headline image
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 ↗
June 04, 2024
Via InvestorPlace
News headline image
7 Penny Biotech Stocks to Triple Your Investment ↗
May 28, 2024
Via InvestorPlace
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via Investor Brand Network
News headline image
Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 07, 2024
Via ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
March 20, 2024
Via AB Newswire
News headline image
Sidoti Events, LLC's Virtual January Micro-Cap Conference
January 15, 2024
Via ACCESSWIRE
News headline image
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape? ↗
December 20, 2023
Via Benzinga
News headline image
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 ↗
December 11, 2023
Via InvestorPlace
News headline image
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations' ↗
December 07, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
December 07, 2023
Via Benzinga
News headline image
The 3 Most Undervalued Cheap Stocks to Buy in September 2023 ↗
September 11, 2023
Via InvestorPlace

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?
Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Anixa Biosciences, Inc. - Common Stock trade on?
Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?
The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market
What is the current price of Anixa Biosciences, Inc. - Common Stock?
The current price of Anixa Biosciences, Inc. - Common Stock is 2.850
When was Anixa Biosciences, Inc. - Common Stock last traded?
The last trade of Anixa Biosciences, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?
The market capitalization of Anixa Biosciences, Inc. - Common Stock is 95.12M
How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?
Anixa Biosciences, Inc. - Common Stock has 95M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap